ProMIS Neurosciences (NasdaqCM:PMN) FY Conference September 10, 2025 12:30 PM ET Speaker0Good afternoon, everyone. Thank you for joining us for our next session at the H. C. Wainwright Global Investment Conference. My name is Joshua Corson, and I'm an equity research associate at H.C. Wainwright. For our next session, I would like to introduce our presenter, Neil Warmah, who is the CEO of Promis Neurosciences. Floor is yours.Speaker1Thanks very much. I appreciate it. Thanks everybody for joining this aftern ...

"The rapid enrollment in PRECISE-AD is a testament to the urgent need to bring new breakthroughs in treatment to Alzheimer's patients and providers," Dr. David Watson, Chief Executive and Founder of the Alzheimer's Research and Treatment Center and one of the treating physicians in the PRECISE-AD trial stated. "I am encouraged by the mechanism of ProMIS's PMN310, which has been designed to specifically target toxic Aβ oligomers, and has the potential to provide a more favorable product profile and significa ...